Cannabinoid receptors promote chronic intermittent hypoxia-induced breast cancer metastasis via IGF-1R/AKT/GSK-3β

Li-Ting Li,Fang-Fang Zhao,Zhi-Mei Jia,Li-Qing Qi,Xi-Zhu Zhang,Lu Zhang,Ying-Ying Li,Jiao-Jiao Yang,Shu-Juan Wang,Hui Lin,Chun-Hao Liu,Dong-Dong An,Ya-Qiong Huang,Xiao-Ling Gao
DOI: https://doi.org/10.1016/j.omto.2021.09.007
2021-12-01
Abstract:The progression of breast cancer is closely related to obstructive sleep apnea-hypopnea syndrome (OSAHS). Low concentrations of cannabinoids promote tumor proliferation. However, the role of cannabinoid receptors (CBs) in chronic intermittent hypoxia (CIH)-induced breast cancer has not been reported. The migration and invasion of MCF-7 and T47D cells were measured by scratch assay and transwell assay. Gene and protein expressions were analyzed by qPCR and Western blotting. Tumor xenograft mice model were established to evaluate the function of CBs. We observed that chronic hypoxia (CH) and CIH increased CBs expression and promoted migration and invasion in breast cancer. Mice grafted with MCF-7 exhibited obvious tumor growth, angiogenesis and lung metastasis in CIH compared with CH and control. In addition, CIH induced CBs expression, which subsequently activated insulin-like growth factor-1 receptor (IGF-1R)/AKT/GSK-3β axis. Knockdown of CBs alleviated CIH-induced migration and invasion of breast cancer in vitro. Furthermore, CIH exaggerated the malignancy of breast cancer and silencing of CBs suppressed tumor growth and metastasis in vivo. Our study contributed to understand the role of CIH in breast cancer development modulation.
oncology,medicine, research & experimental
What problem does this paper attempt to address?